Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japanese Pharma, Hungry For Global Deals, Can Fill Gap of Shrinking Partners - PharmAsia Summit

This article was originally published in PharmAsia News

Executive Summary

SAN FRANCISCO - The number of large Western pharmaceutical companies is shrinking due to M&A activity, and outward-looking Japanese firms of all sizes are quickly becoming an attractive option for biotechs looking for global and regional deals

You may also be interested in...



Platform Start-Up Anaphore And Mitsubishi Tanabe Ink Deal For Autoimmune Therapies

Anaphore, Inc., a La Jolla, CA, start-up with a novel platform for developing trimeric proteins called Atrimers, has partnered with Mitsubishi Tanabe Pharma Corporation to work on autoimmune diseases

Platform Start-Up Anaphore And Mitsubishi Tanabe Ink Deal For Autoimmune Therapies

Anaphore, Inc., a La Jolla, CA, start-up with a novel platform for developing trimeric proteins called Atrimers, has partnered with Mitsubishi Tanabe Pharma Corporation to work on autoimmune diseases

Platform Start-Up Anaphore And Mitsubishi Tanabe Ink Deal For Autoimmune Therapies

Anaphore's novel Atrimer platform creates trivalent protein drugs to bind all three domains on trivalent ligands and receptors, a presumed advantage over two-armed antibodies.

Related Content

Latest News
See All
UsernamePublicRestriction

Register

SC073721

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel